Analyst Research

Report Title Price
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters StreetEvents
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

NephroGenex Inc announces closing of initial public offering


Friday, 14 Feb 2014 11:30am EST 

NephroGenex Inc:Says the closing of its initial public offering of 3,100,000 shares of common stock at a public offering price of $12.00 per share for total gross proceeds of $37,200,000 before underwriting discounts.In addition, it has granted the underwriter a 45-day option to purchase up to an additional 465,000 shares of common stock from NephroGenex to cover over-allotments, if any.Says its stock is listed on The NASDAQ Capital Market under the trading symbol NRX.Aegis Capital Corp. acted as sole book-running manager for the offering. 

Latest Developments for NephroGenex Inc

Company Quote

4.6
0.55 +13.58%
26 Nov 2014